The small intestine absorption test using the [1-13C] labeled substance, and a study of bacterial overgrowth in the intestine.

The small intestine absorption test using the [1-13C] labeled substance, and a study of bacterial overgrowth in the intestine. - The small intestine absorption test using the [1-13C] labeled substance, and a study of bacterial overgrowth.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006637

Enrollment

100

Registered

2011-10-31

Start date

2009-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis, portal hypertension

Interventions

We will enroll control subjects for this study from May, 2009 to April, 2014. After at least 12-h overnight fast, all subjects received substrates of [1-13C] labeled fatty acids or D-xylose using upp

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: he people with or without liver cirrhosis who have a schedule to receive the endoscopic examination for stomach and intestine. All enrolled participants provided written informed consent to research testing under protocols approved by the Institutional Review Boards of Ehime University Hospital (approved number: 0904007).The study protocol conformed to the ethical guidelines of the Declaration of Helsinki.

Exclusion criteria

Exclusion criteria: We exclude the patients with diabetes or abnormality of lipid metabolism. We also exclude the patients who could not receive the examination by upper gastrointestinal tract endoscope due to systemic condition.

Design outcomes

Primary

Measure	Time frame
Time course of breath 13CO2 excretion after loading [1-13C]-labeled substances	—

Secondary

Measure	Time frame
The area under the curve of total breath 13CO2 excretion	—

Countries

Japan

Contacts

Public ContactYasunori Yamamoto

Ehime University Graduate School of Medicine Department of Gastroenterology and Metabology

y79y81@yahoo.com+81-89-960-5308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026